| Literature DB >> 25606375 |
Shu Su1, Min Tang2, Mingjun Zhang3, Chunquan Cheng4, Xiaojun Tang5.
Abstract
BACKGROUND: Although apolipoprotein (apo) CIII gene polymorphisms have proved to be related to the increased serum lipid level in foreign studies, the results have not always been consistent among diverse populations. In addition, the research focuses on the impact of the apoCIII on the serum lipid levels of Han Chinese subjects which was not conducted before.Entities:
Keywords: ANOVA, Analysis of variance; ApoCIII gene; ApoCIII, Apolipoprotein CIII; BMI, Physique index; HDL-C, High density lipoprotein-cholesterol; HTG, Hypertriglyceridaemia; IR, Insulin resistance; LDL-C, Low density lipoprotein-cholesterol; Polymorphism; Serum lipids; TC, Total cholesterol; TG, Triacylglycerol; TRL, Triglyceride-rich lipoprotein; WHR, Waist to hip ratio
Year: 2013 PMID: 25606375 PMCID: PMC4205029 DOI: 10.1016/j.mgene.2013.09.005
Source DB: PubMed Journal: Meta Gene ISSN: 2214-5400
Characteristics of the surveyed men.
| Variable | n | Mean | Std dev | Minimum | Maximum |
|---|---|---|---|---|---|
| AGE (year) | 337 | 48.65 | 4.04 | 39.00 | 68.00 |
| WHR (m) | 337 | 0.93 | 0.05 | 0.79 | 1.10 |
| BMI (kg/m2) | 337 | 25.38 | 3.17 | 17.48 | 34.33 |
| SBP (mm Hg) | 337 | 124.04 | 14.31 | 81.00 | 179.00 |
| DBP (mm Hg) | 337 | 80.03 | 12.56 | 53.00 | 120.00 |
| Weight (kg) | 337 | 72.60 | 9.74 | 53.00 | 104.00 |
Fig. 1Results of the apoCIII DNA sequencing product (C3175G and T3206G) sample.
The relationship between apoCIII C3157G/T3206G gene polymorphisms and blood lipid levels .
| Variable | ApoCIII3175 | ApoCIII3206 | ||||
|---|---|---|---|---|---|---|
| CC (n = 175) | CG (n = 135) | GG (n = 27) | TT (n = 23) | TG (n = 109) | GG (n = 205) | |
| Age | 49.12 ± 3.95 | 48.22 ± 4.07 | 47.25 ± 3.80 | 49.48 ± 4.16 | 48.72 ± 3.87 | 48.47 ± 4.09 |
| TC (mmol/l) | 5.23 ± 0.97 | 5.25 ± 0.85 | 5.40 ± 0.65 | 5.46 ± 1.24 | 5.21 ± 0.98 | 5.24 ± 0.81 |
| TG (mmol/l) | 1.87 ± 1.24 | 2.05 ± 1.45⁎ | 2.54 ± 1.97⁎,△ | 1.65 ± 0.87 | 2.08 ± 1.41 | 1.99 ± 1.45 |
| HDL-C (mmol/l) | 1.18 ± 0.42 | 1.15 ± 0.42 | 1.09 ± 0.22 | 1.22 ± 0.32 | 1.19 ± 0.51 | 1.14 ± 0.35 |
| LDL-C (mmol/l) | 3.21 ± 0.82 | 3.17 ± 0.79 | 3.14 ± 0.63 | 3.46 ± 1.01 | 3.16 ± 0.81 | 3.18 ± 0.76 |
| WHR | 0.94 ± 0.04 | 0.93 ± 0.05 | 0.92 ± 0.05 | 0.94 ± 0.04 | 0.93 ± 0.05 | 0.94 ± 0.05 |
| BMI | 26.46 ± 5.50 | 25.73 ± 3.66 | 25.04 ± 2.43 | 25.52 ± 3.50 | 25.16 ± 2.94 | 26.59 ± 4.43 |
*: P < 0.05, GG vs. CC; △: P < 0.05, GG vs. CG.
The relationship between apoCIII C3157G/T3206G gene polymorphisms and high TG levels .
| Variable | ApoCIII3175 | ApoCIII3206 | ||||
|---|---|---|---|---|---|---|
| CC (n = 49) | CG (n = 36) | GG (n = 13) | TT (n = 8) | TG (n = 36) | GG (n = 54) | |
| TC (mmol/l) | 5.12 ± 0.52 | 5.24 ± 0.78 | 5.78 ± 0.67⁎,△ | 6.69 ± 1.06 | 5.64 ± 0.95 | 5.29 ± 0.71⁎,△ |
| HDL-C (mmol/l) | 1.11 ± 0.52 | 0.98 ± 0.14 | 0.96 ± 0.16 | 1.14 ± 0.25 | 1.13 ± 0.59 | 0.97 ± 0.16 |
| LDL-C (mmol/l) | 2.83 ± 0.60 | 3.01 ± 0.52 | 3.44 ± 0.96⁎,△ | 4.57 ± 0.78 | 3.26 ± 0.83 | 2.99 ± 0.61⁎,△ |
| WHR | 0.95 ± 0.04 | 0.94 ± 0.03 | 0.93 ± 0.04 | 0.96 ± 0.03 | 0.94 ± 0.04 | 0.95 ± 0.04 |
| BMI | 30.73 ± 2.72 | 26.27 ± 2.92 | 25.81 ± 2.89 | 26.49 ± 1.90 | 25.49 ± 2.43 | 30.71 ± 2.73 |
*: P < 0.05, GG vs. CC/TT; △: P < 0.05, GG vs. CG/TG.
Multiple unconditional logistic regression analysis for TG.
| Gene | Genotype | Adjusted OR (95% CI) | Adjusted P-value |
|---|---|---|---|
| ApoCIII3175 | CC | 1.00 | |
| CG | 1.991 (1.475–2.687) | < 0.01 | |
| GG | 1.967 (1.406–2.752) | < 0.01 | |
| ApoCIII3206 | TT | 1.00 | |
| TG | 0.336 (0.219–0.516) | < 0.01 | |
| GG | 1.358 (0.953–1.935) | 0.0904 |
Multiple unconditional logistic regression, adjusted by AGE, BMI, and WHR.